Blog
-
Pharmaceutical Intermediates Market
The pharmaceutical intermediate market is at the forefront of a complex network of drug development and manufacturing and is key to the production of active pharmaceutical intermediates.Pānuitia atu -
He aha nga keehi "neuro" me "ocular" ranei?
Ko te ngeru "Neuro" ko te FIP kua whiti i te arai roro toto me nga tohu ko nga raru o te punaha nerve pokapū. Ataxia (te ngoikore o oku waewae o muri), te kore e taea te peke katoa me te kore e whakaroa, te kore o te ruruku me te hopu. Ko te whai waahi o te mata, he mea noa ki te ahua neurological mai i te mea e hono tata ana nga kanohi me te roro, penei te ahua:Pānuitia atu -
Ko te GS-441524 te waahanga koiora o Remdesivir
Ko te GS-441524 te waahanga koiora o Remdesivir a kua whakamahia whanuitia puta noa i te ao ki te rongoa i nga ngeru o te peritonitis infectious peritonitis (FlP) mo te 18 marama neke atu. Ko te FIP he mate noa, he mate tino mate o nga ngeru.Pānuitia atu -
He paura hou 28578-16-7 PMK ethyl glycidate
Na te piki haere o te hiahia o nga kaihoko, i timata ano matou ki te whakapau i te wa me te kaha ki te haumi ki te rangahau me te whanaketanga o tenei hua hou paura pmk, kua tino pai ake te ma. He pai ake te rokiroki, a ka pai nga kaihoko ki te tuku ota nui.Pānuitia atu